Intensive dose of rosuvastatin (40 mg/day), initiated early and continued for 12 weeks, in ‘very high’ risk or ‘high’ risk Indian patients

Bibliographic Details
Main Authors:	C.P. Shah, B.P. Shah, N.C. Krishnamani, A. Mehta, P. Moorthy, G.P. Ratnaparkhi, S. Dani, S.S. Lakshmanan, M.S.S. Mukharjee, K.M.K. Reddy, B.B. Chanana, S. Suryawanshi, J. Karankumar
Format:	Article
Language:	English
Published:	Elsevier 2014-11-01
Series:	Indian Heart Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S0019483214003654

Internet